Mice with multiple myeloma, an incurable malignancy of the bone marrow, respond dramatically to the treatment with this drug.
Miševi s multiplim mijelomima, neizliječivim malignitetom koštane srži, dramatično reagiraju na liječenje ovim lijekom.